In contrast to these studies, Turhal et al. (35) suggested that ERCC1 expression could not be the only cause of cisplatin resistance because they only found ERCC1 expression in less than 2% (1/61 patients), whereas 90% of patients with HCC were resistant to cisplatin. Here, ERCC1 is linked to hepatocellular carcinoma.